Lead (Pb)

Overview

Lead is a non-essential, cumulative toxicant that partitions predominantly into red blood cells (99%), where it binds and inhibits δ-aminolevulinic acid dehydratase (ALAD), disrupting heme synthesis and serving as a sensitive functional biomarker of exposure.^[1] Bone is the major long-term reservoir (>90% of the body burden in adults), enabling chronic recirculation years after exposure ceases.^[2] At the population level, public-health benchmarks have tightened: the U.S. CDC’s pediatric blood lead reference value is 3.5 µg/dL, and EPA’s 2024 Lead and Copper Rule Improvements lowered the drinking-water action level to 10 µg/L, underscoring that there is no known safe level.^[3] Microbiome-relevant evidence spans humans and models, showing that prenatal and chronic low-dose exposures are associated with decreased gut alpha-diversity, shifts in taxa, and functional alterations in children and adults, with plausible links to barrier injury and immune modulation.^[4] These host–metal–microbe interactions create selection pressures that can favor metal-resistance determinants and, in some settings, co-selection of antimicrobial resistance (AMR).

Chemical speciation across host niches

Lead, a toxic heavy metal, exists in several chemical forms in the human body, with its speciation significantly affecting its bioavailability, toxicity, and distribution across various tissues.^[5] Upon exposure, lead primarily enters the bloodstream as an inorganic ion (Pb²⁺), but it can also bind to proteins, lipids, and other biomolecules, forming complexes that enhance its retention in tissues.^[6] A significant fraction of lead is deposited in bones, where it mimics calcium, binding to hydroxyapatite and remaining stored for years.^[7] Bone lead serves as a reservoir, releasing the metal into the bloodstream during periods of bone turnover, such as pregnancy or osteoporosis.^[8] In the kidneys, lead interferes with sulfhydryl groups in enzymes, leading to renal dysfunction, while in the brain, it crosses the blood-brain barrier, where it disrupts synaptic function and neurotransmission by interfering with calcium signaling pathways, contributing to neurotoxicity.^[9][10] Lead can form organic compounds such as tetraethyl lead, which are absorbed more rapidly and present higher acute toxicity.^[11] The speciation of lead in various body compartments determines its toxicological impact, influencing both acute and chronic health effects, including its potential to disrupt the gut microbiome.

Microbial acquisition and regulation

Bacteria do not intentionally absorb lead (Pb²⁺) for nutrition; instead, it enters the cell unintentionally via porins and ion transport pathways that typically carry essential metals like calcium and zinc.^[12] Lead mimics these ions, causing accidental uptake. Once inside, lead can be toxic, disrupting biological processes. To counteract this, bacteria have evolved resistance systems such as the pbr operon in Cupriavidus metallidurans CH34.^[13] This operon includes PbrR, which senses lead and activates the pbr promoter, leading to the production of proteins that help detoxify lead.^[14] PbrA, a P1B-type ATPase, actively pumps lead out of the cell, while PbrB helps precipitate lead on the bacterial surface. PbrC and PbrD further sequester lead. P-type ATPases like ZntA can efflux lead, illustrating widespread resistance mechanisms across bacteria in metal-contaminated environments.^[15] Lead exposure also triggers general stress responses, activating alternative σ factors that help bacteria adapt to stress. These responses can affect motility and changes in the bacterial envelope, which are essential for survival in metal-contaminated habitats.

Metal toolkit

System/role	Representative components and notes
Importer	None dedicated to Pb(II) (adventitious entry via porins/ion transporters).[16]
Regulator	PbrR (MerR family), Pb(II)-responsive transcriptional activator.[17]
Storage	PbrD is implicated in Pb binding/sequestration.[18]
Efflux	PbrA (P1B-type ATPase); ZntA can export Pb(II) in some bacteria.[19]

Nutritional immunity and host sequestration

Nutritional immunity is a defense mechanism where the host limits the availability of lead to pathogens and harmful organisms by sequestering it in less toxic forms. Lead, which competes with essential metals like calcium, zinc, and iron, is stored primarily in bones and teeth, where it mimics calcium and binds to hydroxyapatite, acting as a long-term reservoir.^[20] During periods of bone turnover, lead is released into the bloodstream, and metallothioneins, small proteins that bind metals, help sequester lead in non-toxic forms, reducing its bioavailability.^[21] Iron and calcium-binding proteins, such as ferritin, bind to lead in the bloodstream, further reducing its potential for toxicity.^[22] These mechanisms work together to reduce lead’s toxic effects on the body, protecting against its neurotoxic, renal, and cardiovascular impacts.

Host sequestration

Host Factor	Microbial Consequence for Metal-Dependent Enzymes or Growth

Bone Storage of Lead

Reduces bioavailability of lead, limiting its toxicity to microbes by preventing excess lead in circulation.[23]

Metallothioneins

Bind lead, preventing it from interfering with microbial enzymes and cellular functions.[24]

Blood-Brain Barrier

Restricts microbial exposure to lead in the brain, preventing lead-induced disruption of microbial growth and function.[25]

Intestinal Mucosa

Limits the absorption of lead into the bloodstream, reducing microbial exposure to toxic levels of lead.[26]

Metallophores and community competition

Metallophores and related metal‐binding systems shape community competition under lead pressure by rewriting the local “metal economy” that determines which taxa access or withstand Pb²⁺. In the attached review, small, cysteine-rich chelators, metallothioneins and phytochelatins on the microbial/plant side and calprotectin on the host side, are highlighted as key detoxification proteins; by sequestering divalent metals they shrink the free Pb²⁺ pool and blunt mismetallation stress that would otherwise penalize sensitive microbes and destabilize barrier tissues.^[27] Lead’s ionic mimicry intensifies this competition: Pb²⁺ substitutes for Ca²⁺/Zn²⁺ at protein sites, deranging signaling and redox balance, so communities with robust sequestration/export toolkits hold an ecological edge. In the gut, ligand chemistry further tilts niches: thiol and reducing ligands (e.g., methionine, cysteine, ascorbate) keep lead soluble and bioavailable, whereas Fe, Zn, and Ca suppress Pb²⁺ uptake via shared mucosal receptors, concrete evidence that cation competition can gate lead entry and thus reshape downstream community pressures.^[28][29]

Metallophores and capture

System or ligand	Comment on Pb capture
Desferrioxamine B	Forms measurable Pb(II) complexes; can mobilize or buffer Pb depending on context.[30]
Desferricoprogen	High-stability Pb(II) complexes reported; stronger than DFO-B in some systems.[31]

Mismetallation and cross-metal crosstalk

Pb(II) is a soft, thiophilic cation that readily binds cysteine-rich sites and can displace native metals in proteins.^[32] In bacteria, Pb stress risks mismetallation of Zn-dependent enzymes and metal-sensing regulators (e.g., MerR-family), perturbing transcriptional programs and stress defenses.^[33] Pb can also mimic or compete with Ca²⁺ at binding sites, altering envelope processes and signaling; at community interfaces, sulfide-driven PbS precipitation competes with phosphate-driven mineralization, changing where Pb is sequestered and which taxa are exposed.^[34] Together these interactions re-wire metal homeostasis and can push communities toward exporters, phosphate liberation, and EPS-rich biofilm states that lower intracellular Pb but favor persistence.

Mismetallation map

At-risk enzyme class	Wrong-metal outcome; clinical note
Zn-dependent enzymes (e.g., dehydratases, proteases)	Pb displaces Zn at thiolate sites and causes loss of function; links to oxidative stress and fitness costs.[35]
Metal sensors (MerR-family)	Aberrant activation or repression under Pb(II) challenge; shifts resistance regulons.[36]
Ca-binding envelope factors	Ca²⁺ mimicry perturbs envelope stability/signaling; may alter adhesion/biofilm programs.[37]

Virulence Pathways

Lead reprograms virulence not by creating new factors but by reweighting metal-responsive circuits that control colonization, biofilm architecture, and stress tolerance. In Cupriavidus metallidurans, Pb(II) binding to the MerR-family regulator PbrR activates the divergently transcribed pbr operon, driving a coordinated response that includes P-type ATPase efflux (PbrA), accessory functions in periplasmic handling, and promoter remodeling.^[38][39] This induction lowers pericellular free Pb and stabilizes envelope function at surfaces where persistence matters. Cross-specificity with Zn homeostasis extends this logic to enteric pathogens and pathobionts: the E. coli transporter ZntA exports Zn/Cd and Pb, with activity favored when metals are present as metal-thiolate complexes, directly linking soft-metal stress to ATPase-driven detoxification that can sustain growth under host pressure.^[40] Periplasmic handling can culminate in precipitation of Pb as insoluble salts, further depleting bioavailable ion near cells; genetic dissection of pbrABCD shows this module is necessary and sufficient for robust Pb resistance in C. metallidurans.^[41] Heavy-metal pressure simultaneously shifts social traits: quorum systems can gate Pb precipitation and matrix output (e.g., Vibrio harveyi links LuxO/AI-1/AI-2 signaling to Pb precipitation), while EPS-rich biofilms common under metal stress immobilize Pb and shield embedded cells from host defenses.^[42]

Virulence targets to MBTI

Targetable node	MBTI concept with predicted effect on pathogenesis
PbrR–pbr regulon activation (efflux/handling)	Quorum quenching (QQ strains/enzymes) to desynchronize Pb-linked matrix programs, leading to thinner biofilms and less immune evasion.[43]
Quorum-controlled Pb precipitation and matrix output	Biofilm dispersal (DNase/EPS-glycosidases) paired with commensal reseeding leads to decreased persistence and toxin/efflux expression thresholds.[44][45]
EPS-rich biofilm matrix under metal stress	Biofilm dispersal (DNase/EPS-glycosidases) paired with commensal reseeding leading to decreased persistence and toxin/efflux expression thresholds.[46][47]

Exposure to microbiome outcomes

Exposure to lead significantly disrupts the gut microbiome by altering microbial diversity and composition, leading to a shift in the balance between beneficial and pathogenic microbes. Studies have shown that even low concentrations of Pb exposure tends to increase Firmicutes while decreasing Bacteroidetes, disrupting the F/B ratio and potentially harming health.^[48] Human cohort data indicate prenatal Pb exposure associates with reduced α-diversity and compositional shifts in children at 9–11 years; cross-sectional studies in contaminated settings likewise show diversity and functional disruptions in adults.^[49] In animals, chronic low-dose Pb in drinking water alters communities and metabolites, with barrier perturbation.^[50][51] As exposure increases, the microbiome becomes increasingly dominated by opportunistic pathogens with enhanced resistance mechanisms, including efflux pumps and metal-resistance operons. This shift not only affects microbial interactions but also compromises gut barrier integrity and immune function.^[52] In severe cases, high Pb exposure is linked to systemic inflammatory responses and alterations in metabolic pathways, further exacerbating health risks associated with lead toxicity.^[53] These changes in the microbiome contribute to a range of diseases, from gastrointestinal disorders to neurological and metabolic disturbances, underlining the importance of considering microbiome health in managing lead exposure.

Exposure thresholds to selection

Exposure or Concentration Range	Predicted microbiome selection signal
Drinking water 5–10 µg/L	Community shifts possible in susceptible hosts; favoring EPS-rich, metal-tolerant taxa.[54][55]
Blood lead 2–5 µg/dL (children)	Subclinical selection; lower α-diversity and taxa changes observed longitudinally.[56]

MBTIs and clinical strategies

Microbiome-targeted interventions (MBTIs) for Pb aim to lower free luminal Pb, divert it to insoluble phases, and strengthen barrier function. High-fiber diets and ligands that favor distal complexation/precipitation (e.g., fermentable fibers raising sulfide in the colon within safe physiological ranges) can reduce bioavailability.^[57] Certain lactic-acid bacteria and enterococci exhibit strong biosorption of Pb on cell walls/EPS, suggesting probiotic consortia could immobilize Pb in lumenal solids; meanwhile, butyrate-producing commensals support mucosal defense.^[58][59] These are adjunctive to primary hazard control (remediation, water treatment) and clinical care.

Intervention and expected microbial effect

Intervention	Expected Microbial or Host-Niche Effect
Probiotics	Support beneficial microbial growth and enhance gut barrier function, potentially reducing lead-induced toxicity.[60][61]
Fecal microbiota transplantation (FMT)	Restoring microbial diversity and improving gut health after lead exposure can potentially aid in detoxification.[62] However, there is also a risk of transferring pathogens or pathogens resistant to Pb.
Chelation therapy	Bind and remove lead from the body, reducing its toxic effects and potentially restoring microbial balance.[63] However, overuse may disrupt essential microbial metal interactions.
Dietary modifications	Improve microbial health by reducing oxidative stress from lead exposure and supporting detoxification pathways.[64]
Lead exposure reduction (environmental control)	Reduces lead uptake, minimizing the disruption of the microbiome and restoring healthier microbial diversity.

Knowledge gaps and priorities

Lead–microbiome studies need standardized exposure metrics linking free-ion activity to community outcomes across body sites. Pb-specific metallophore ecology remains underexplored, as does quantitative mapping of mismetallation in bacterial targets at environmental doses. Longitudinal human cohorts that integrate bone Pb (K-XRF), repeated blood Pb, metagenomes/transcriptomes, and metabolomics will clarify dose–response and recovery trajectories. Finally, interventional trials should test whether biosorption-focused probiotics, dietary fiber strategies, or combined approaches measurably lower luminal free Pb and mitigate selection for metal/antibiotic co-resistance, always alongside primary exposure abatement.

The primary uncertainties hindering clinical application of Pb–microbiome research include unclear dose–response relationships between Pb exposure and microbiome alterations, a lack of longitudinal human data tracking Pb’s impact over time, and inadequate standardization of analytical techniques for microbiome profiling. First, the specific Pb exposure levels required to induce microbiome dysbiosis are poorly defined, with inconsistent findings across studies. Second, most research remains cross-sectional, preventing a clear understanding of long-term effects and temporal dynamics. Lastly, the variability in sequencing platforms and data analysis methods across studies limits reproducibility and comparability. To resolve these gaps, standardized exposure assessment protocols, longitudinal cohort studies, and harmonized microbiome profiling methods are essential for generating reliable data to inform clinical decision-making and treatment strategies.

Research Feed

Update History

References

1. Lead and δ-Aminolevulinic Acid Dehydratase Polymorphism: Where Does It Lead? A Meta-Analysis.. Scinicariello, F., Murray, H. E., Moffett, D. B., Abadin, H. G., Sexton, M. J., & Fowler, B. A. (2006).. (Environmental Health Perspectives, 115(1), 35.)
2. Public and occupational health risks related to lead exposure updated according to present-day blood lead levels.. Yu, Y., Yang, W., Hara, A., Asayama, K., Roels, H. A., Nawrot, T. S., & Staessen, J. A. (2023).. (Hypertension Research, 46(2), 395-407.)
3. Update of the Blood Lead Reference Value — United States, 2021.. Ruckart, P. Z., Jones, R. L., Courtney, J. G., LeBlanc, T. T., Jackson, W., Karwowski, M. P., Cheng, Y., Allwood, P., Svendsen, E. R., & Breysse, P. N. (2021).. (Morbidity and Mortality Weekly Report, 70(43), 1509.)
4. Prenatal Lead Exposure is Negatively Associated with the Gut Microbiome in Childhood.. Eggers, S., Midya, V., Bixby, M., Gennings, C., Torres-Olascoaga, L. A., Walker, R. W., Wright, R. O., Arora, M., & Téllez-Rojo, M. M. (2023).. (MedRxiv, 2023.05.10.23289802.)
5. MOLECULAR MECHANISMS OF LEAD NEUROTOXICITY.. Virgolini, M. B., & Aschner, M. (2021).. (Advances in Neurotoxicology, 5, 159.)
6. MOLECULAR MECHANISMS OF LEAD NEUROTOXICITY.. Virgolini, M. B., & Aschner, M. (2021).. (Advances in Neurotoxicology, 5, 159.)
7. Metal toxicity and opportunistic binding of Pb2 + in proteins.. Kirberger, M., Wong, H. C., Jiang, J., & Yang, J. J. (2013).. (Journal of Inorganic Biochemistry, 125, 40-49.)
8. Lead as a Risk Factor for Osteoporosis in Post-menopausal Women.. Manocha, A., Srivastava, L. M., & Bhargava, S. (2016).. (Indian Journal of Clinical Biochemistry, 32(3), 261.)
9. MOLECULAR MECHANISMS OF LEAD NEUROTOXICITY.. Virgolini, M. B., & Aschner, M. (2021).. (Advances in Neurotoxicology, 5, 159.)
10. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
11. Organic Lead Toxicology.. Patocka, Jiri. (2008).. (Acta Medica (Hradec Kralove, Czech Republic). 51. 209-213.)
12. Lead: Natural Occurrence, Toxicity to Organisms and Bioremediation by Lead-degrading Bacteria: A Comprehensive Review.. Ashkan MF.. (J Pure Appl Microbiol. 2023;17(3):1298-1319.)
13. Cysteine coordination of Pb(II) is involved in the PbrR-dependent activation of the lead-resistance promoter, PpbrA, from Cupriavidus metallidurans CH34.. Hobman, J.L., Julian, D.J. & Brown, N.L.. (BMC Microbiol 12, 109 (2012).)
14. Lead(II) resistance in Cupriavidus metallidurans CH34: interplay between plasmid and chromosomally-located functions.. Taghavi S, Lesaulnier C, Monchy S, Wattiez R, Mergeay M, van der Lelie D.. (Antonie Van Leeuwenhoek. 2009 Aug;96(2):171-82.)
15. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites and Metabolic Pathways.. Gao, B., Chi, L., Mahbub, R., Bian, X., Tu, P., Ru, H., & Lu, K. (2017).. (Chemical Research in Toxicology, 30(4), 996.)
16. Lead: Natural Occurrence, Toxicity to Organisms and Bioremediation by Lead-degrading Bacteria: A Comprehensive Review.. Ashkan MF.. (J Pure Appl Microbiol. 2023;17(3):1298-1319.)
17. Cysteine coordination of Pb(II) is involved in the PbrR-dependent activation of the lead-resistance promoter, PpbrA, from Cupriavidus metallidurans CH34.. Hobman, J.L., Julian, D.J. & Brown, N.L.. (BMC Microbiol 12, 109 (2012).)
18. An efflux transporter PbrA and a phosphatase PbrB cooperate in a lead-resistance mechanism in bacteria.. Hynninen, A., Touzé, T., Pitkänen, L., Mengin-Lecreulx, D., & Virta, M. (2009).. (Molecular Microbiology, 74(2), 384-394.)
19. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites and Metabolic Pathways.. Gao, B., Chi, L., Mahbub, R., Bian, X., Tu, P., Ru, H., & Lu, K. (2017).. (Chemical Research in Toxicology, 30(4), 996.)
20. Public and occupational health risks related to lead exposure updated according to present-day blood lead levels.. Yu, Y., Yang, W., Hara, A., Asayama, K., Roels, H. A., Nawrot, T. S., & Staessen, J. A. (2023).. (Hypertension Research, 46(2), 395-407.)
21. Heavy Metals and Human Health: Possible Exposure Pathways and the Competition for Protein Binding Sites.. Witkowska, D., Słowik, J., & Chilicka, K. (2021).. (Molecules, 26(19), 6060.)
22. Factors affecting the absorption and excretion of lead in the rat.. Conrad, M. E., & Barton, J. C. (1978).. (Gastroenterology, 74(4), 731-740.)
23. Heavy metals: toxicity and human health effects.. Jomova, K., Alomar, S.Y., Nepovimova, E. et al.. (Arch Toxicol 99, 153–209 (2025).)
24. Heavy Metals and Human Health: Possible Exposure Pathways and the Competition for Protein Binding Sites.. Witkowska, D., Słowik, J., & Chilicka, K. (2021).. (Molecules, 26(19), 6060.)
25. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
26. Factors affecting the absorption and excretion of lead in the rat.. Conrad, M. E., & Barton, J. C. (1978).. (Gastroenterology, 74(4), 731-740.)
27. Heavy Metals and Human Health: Possible Exposure Pathways and the Competition for Protein Binding Sites.. Witkowska, D., Słowik, J., & Chilicka, K. (2021).. (Molecules, 26(19), 6060.)
28. MOLECULAR MECHANISMS OF LEAD NEUROTOXICITY.. Virgolini, M. B., & Aschner, M. (2021).. (Advances in Neurotoxicology, 5, 159.)
29. Factors affecting the absorption and excretion of lead in the rat.. Conrad, M. E., & Barton, J. C. (1978).. (Gastroenterology, 74(4), 731-740.)
30. Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator.. Bellotti, D., & Remelli, M. (2021).. (Molecules, 26(11), 3255.)
31. Structure-based differences between the metal ion selectivity of two siderophores desferrioxamine B (DFB) and desferricoprogen (DFC): Why DFC is much better Pb(II) sequestering agent than DFB?. Farkas, E., Bátka, D., Kremper, G., & Pócsi, I. (2008).. (Journal of Inorganic Biochemistry, 102(8), 1654-1659)
32. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
33. Cysteine coordination of Pb(II) is involved in the PbrR-dependent activation of the lead-resistance promoter, PpbrA, from Cupriavidus metallidurans CH34.. Hobman, J.L., Julian, D.J. & Brown, N.L.. (BMC Microbiol 12, 109 (2012).)
34. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
35. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
36. Cysteine coordination of Pb(II) is involved in the PbrR-dependent activation of the lead-resistance promoter, PpbrA, from Cupriavidus metallidurans CH34.. Hobman, J.L., Julian, D.J. & Brown, N.L.. (BMC Microbiol 12, 109 (2012).)
37. Neurotoxic Effects and Biomarkers of Lead Exposure: A Review.. Sanders, T., Liu, Y., Buchner, V., & Tchounwou, P. B. (2008).. (Reviews on Environmental Health, 24(1), 15.)
38. Transcriptional activation of MerR family promoters in Cupriavidus metallidurans CH34.. Julian DJ, Kershaw CJ, Brown NL, Hobman JL.. (Antonie Van Leeuwenhoek. 2009 Aug;96(2):149-59.)
39. Cloning and Functional Analysis of the pbr Lead Resistance Determinant of Ralstonia metallidurans CH34.. Borremans, B., Hobman, J. L., Provoost, A., & Brown, N. L. (2001).. (Journal of Bacteriology, 183(19), 5651.)
40. Cd(II), Pb(II), and Zn(II) ions regulate expression of the metal‐transporting P‐type ATPase ZntA in Escherichia coli.. Binet, M. R. B., & Poole, R. K. (2000).. (FEBS Letters, 473(1), 67–70.)
41. An efflux transporter PbrA and a phosphatase PbrB cooperate in a lead-resistance mechanism in bacteria.. Hynninen, A., Touzé, T., Pitkänen, L., Mengin-Lecreulx, D., & Virta, M. (2009).. (Molecular Microbiology, 74(2), 384-394.)
42. Lead Precipitation by Vibrio harveyi: Evidence for Novel Quorum-Sensing Interactions.. Mire, C. E., Tourjee, J. A., Ramanujachary, K. V., & Hecht, G. B. (2004).. (Applied and Environmental Microbiology, 70(2), 855.)
43. Lead Precipitation by Vibrio harveyi: Evidence for Novel Quorum-Sensing Interactions.. Mire, C. E., Tourjee, J. A., Ramanujachary, K. V., & Hecht, G. B. (2004).. (Applied and Environmental Microbiology, 70(2), 855.)
44. Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms.. Pinto, R. M., Soares, F. A., Reis, S., Nunes, C., & Van Dijck, P. (2020).. (Frontiers in Microbiology, 11, 535344.)
45. Combined DNase and Proteinase Treatment Interferes with Composition and Structural Integrity of Multispecies Oral Biofilms.. Karygianni, L., Attin, T., & Thurnheer, T. (2020).. (Journal of Clinical Medicine, 9(4), 983.)
46. Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms.. Pinto, R. M., Soares, F. A., Reis, S., Nunes, C., & Van Dijck, P. (2020).. (Frontiers in Microbiology, 11, 535344.)
47. Combined DNase and Proteinase Treatment Interferes with Composition and Structural Integrity of Multispecies Oral Biofilms.. Karygianni, L., Attin, T., & Thurnheer, T. (2020).. (Journal of Clinical Medicine, 9(4), 983.)
48. Lead exposure in relation to gut homeostasis, microbiota, and metabolites.. Tao, Y., Liu, D., Shi, Q., Sun, Q., Liu, C., & Zeng, X. (2025).. (Applied and Environmental Microbiology, 91(7), e00372-25.)
49. Prenatal Lead Exposure is Negatively Associated with the Gut Microbiome in Childhood.. Eggers, S., Midya, V., Bixby, M., Gennings, C., Torres-Olascoaga, L. A., Walker, R. W., Wright, R. O., Arora, M., & Téllez-Rojo, M. M. (2023).. (MedRxiv, 2023.05.10.23289802.)
50. Oral Supplementation of Lead-Intolerant Intestinal Microbes Protects Against Lead (Pb) Toxicity in Mice.. Zhai, Q., Qu, D., Feng, S., Yu, Y., Yu, L., Tian, F., Zhao, J., Zhang, H., & Chen, W. (2020).. (Frontiers in Microbiology, 10, 3161.)
51. Multi-Omics Reveals that Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites and Metabolic Pathways.. Gao, B., Chi, L., Mahbub, R., Bian, X., Tu, P., Ru, H., & Lu, K. (2017).. (Chemical Research in Toxicology, 30(4), 996.)
52. Lead exposure in relation to gut homeostasis, microbiota, and metabolites.. Tao, Y., Liu, D., Shi, Q., Sun, Q., Liu, C., & Zeng, X. (2025).. (Applied and Environmental Microbiology, 91(7), e00372-25.)
53. Oral Supplementation of Lead-Intolerant Intestinal Microbes Protects Against Lead (Pb) Toxicity in Mice.. Zhai, Q., Qu, D., Feng, S., Yu, Y., Yu, L., Tian, F., Zhao, J., Zhang, H., & Chen, W. (2020).. (Frontiers in Microbiology, 10, 3161.)
54. Lead in drinking water – An ongoing public health concern?.. Jarvis, Peter & Fawell, John. (2021).. (Current Opinion in Environmental Science & Health. 20. 100239.)
55. Interaction of Heavy Metal Lead with Gut Microbiota: Implications for Autism Spectrum Disorder.. Tizabi, Y., Bennani, S., El Kouhen, N., Getachew, B., & Aschner, M. (2023).. (Biomolecules, 13(10), 1549.)
56. Prenatal Lead Exposure is Negatively Associated with the Gut Microbiome in Childhood.. Eggers, S., Midya, V., Bixby, M., Gennings, C., Torres-Olascoaga, L. A., Walker, R. W., Wright, R. O., Arora, M., & Téllez-Rojo, M. M. (2023).. (MedRxiv, 2023.05.10.23289802.)
57. Lead exposure in relation to gut homeostasis, microbiota, and metabolites.. Tao, Y., Liu, D., Shi, Q., Sun, Q., Liu, C., & Zeng, X. (2025).. (Applied and Environmental Microbiology, 91(7), e00372-25.)
58. Bioremoval of lead (pb) salts from synbiotic milk by lactic acid bacteria.. Alizadeh, A. M., Hosseini, H., Mohseni, M., Mohammadi, M., Hosseini, J., Eskandari, S., Sohrabvandi, S., & Aminzare, M. (2025).. (Scientific Reports, 15, 9101.)
59. The Involvement of Lactic Acid Bacteria and Their Exopolysaccharides in the Biosorption and Detoxication of Heavy Metals in the Gut.. Wang Y, Han J, Ren Q, Liu Z, Zhang X, Wu Z.. (Biol Trace Elem Res. 2024 Feb;202(2):671-684.)
60. Lead exposure in relation to gut homeostasis, microbiota, and metabolites.. Tao, Y., Liu, D., Shi, Q., Sun, Q., Liu, C., & Zeng, X. (2025).. (Applied and Environmental Microbiology, 91(7), e00372-25.)
61. Characterization of lactic acid bacteria-based probiotics as potential heavy metal sorbents.. Bhakta, J. & Ohnishi, K & Munekage, Y & Iwasaki, Kozo & Wei, Ming. (2012).. (Journal of applied microbiology. 112. 1193-206.)
62. Oral Supplementation of Lead-Intolerant Intestinal Microbes Protects Against Lead (Pb) Toxicity in Mice.. Zhai, Q., Qu, D., Feng, S., Yu, Y., Yu, L., Tian, F., Zhao, J., Zhang, H., & Chen, W. (2020).. (Frontiers in Microbiology, 10, 3161.)
63. Chelation in Metal Intoxication.. Flora, S. J., & Pachauri, V. (2010).. (International Journal of Environmental Research and Public Health, 7(7), 2745.)
64. Lead exposure in relation to gut homeostasis, microbiota, and metabolites.. Tao, Y., Liu, D., Shi, Q., Sun, Q., Liu, C., & Zeng, X. (2025).. (Applied and Environmental Microbiology, 91(7), e00372-25.)